- Latest available (Revised)
- Original (As made)
This is the original version (as it was originally made). This item of legislation is currently only available in its original format.
Regulation 2(1)
1 Drug | 2 Patient | 3 Purpose |
---|---|---|
Acetylcysteine Granules | Any patient | Treatment of abdominal complications associated with cystic fibroses |
Carbocisteine | A patient under the age of 18 who has undergone a tracheostomy | Treatment of any condition which, through damage or disease, affects the airways and has required a tracheostomy |
Clobazam | Any patient | Treatment of epilepsy |
Cyanocobalamin Tablets | Any patient who is a vegan or who has a proven vitamin B12 deficiency of dietary origin | Treatment or prevention of vitamin B12 deficiency |
Niferex Elixir 30 ml Paediatric Dropper Bottle | Infants Born Prematurely | Prophylaxis and Treatment of Iron Deficiency |
Nizoral Cream | Any Patient | Treatment of Seborrhoeic Dermatitis and Pityriasis Versicolor |
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include: